Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - SYNAGEVA BIOPHARMA CORP | d375156d8k.htm |
| EX-99.1 - AUDITED FINANCIAL STATEMENTS OF TRIMERIS - SYNAGEVA BIOPHARMA CORP | d375156dex991.htm |
| EX-99.2 - UNAUDITED CONDENSED FINANCIAL STATEMENTS OF TRIMERIS - SYNAGEVA BIOPHARMA CORP | d375156dex992.htm |
| EX-99.3 - UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS OF SYNAGEVA - SYNAGEVA BIOPHARMA CORP | d375156dex993.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement (Form S-3 No. 333-181621) of Synageva BioPharma Corp. and related Prospectus of our report dated March 14, 2011, except for Note 12, as to which the date is July 6, 2012, with respect to the financial statements of Trimeris Inc. included in its Current Report on Form 8-K dated July 6, 2012, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP
Raleigh, North Carolina
July 6, 2012